Nifty
:
25423.60
Sensex
:
83013.96
93.35 (0.37%)
320.25 (0.39%)
Nifty
Sensex
:
:
25423.60
83013.96
93.35 (0.37%)
320.25 (0.39%)

Bal Pharma Ltd.

Pharmaceuticals & Drugs

Rating :
43/99

BSE: 524824 | NSE: BALPHARMA

NSE BSE
84.20
18-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  90
  •  90.89
  •  83.65
  •  89.69
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  171829
  •  14694662.9
  •  140.95
  •  78.06

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 134.53
  • 18.80
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 276.86
  • 1.42%
  • 1.73

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.86%
  • 0.77%
  • 32.41%
  • FII
  • DII
  • Others
  • 0.15%
  • 0.00%
  • 15.81%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.33
  • 3.88
  • -0.13

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.19
  • 3.84
  • 3.34

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.74
  • 8.78
  • 41.10

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.00
  • 28.30
  • 35.86

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.04
  • 2.39
  • 2.41

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.23
  • 10.35
  • 9.36

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
65.87
74.36
-11.42%
81.88
94.63
-13.47%
73.15
81.66
-10.42%
73.69
92.54
-20.37%
Expenses
59.81
67.89
-11.90%
74.23
85.03
-12.70%
65.40
73.87
-11.47%
66.00
84.84
-22.21%
EBITDA
6.06
6.47
-6.34%
7.64
9.59
-20.33%
7.76
7.80
-0.51%
7.70
7.70
0.00%
EBIDTM
9.20%
8.69%
9.33%
10.14%
10.61%
9.55%
10.44%
8.32%
Other Income
0.72
0.82
-12.20%
1.08
2.45
-55.92%
0.51
0.10
410.00%
-0.21
0.14
-
Interest
4.05
4.24
-4.48%
3.95
4.14
-4.59%
5.01
3.66
36.89%
3.65
3.82
-4.45%
Depreciation
2.52
2.43
3.70%
2.18
2.16
0.93%
2.69
2.96
-9.12%
2.48
2.42
2.48%
PBT
0.21
0.62
-66.13%
2.59
5.75
-54.96%
0.57
1.27
-55.12%
1.36
1.60
-15.00%
Tax
0.00
0.36
-100.00%
-2.83
0.22
-
0.05
0.42
-88.10%
0.32
0.63
-49.21%
PAT
0.21
0.26
-19.23%
5.42
5.53
-1.99%
0.52
0.85
-38.82%
1.04
0.97
7.22%
PATM
0.32%
0.35%
6.62%
5.85%
0.71%
1.04%
1.41%
1.05%
EPS
0.13
0.16
-18.75%
3.41
3.46
-1.45%
0.30
0.56
-46.43%
0.65
0.60
8.33%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
294.59
303.08
339.22
304.22
281.21
250.53
171.09
225.01
209.29
228.91
198.32
Net Sales Growth
-14.16%
-10.65%
11.50%
8.18%
12.25%
46.43%
-23.96%
7.51%
-8.57%
15.42%
 
Cost Of Goods Sold
152.35
143.11
175.79
158.95
155.74
140.87
75.74
104.04
88.57
103.94
94.06
Gross Profit
142.24
159.98
163.43
145.27
125.48
109.66
95.35
120.96
120.71
124.97
104.25
GP Margin
48.28%
52.78%
48.18%
47.75%
44.62%
43.77%
55.73%
53.76%
57.68%
54.59%
52.57%
Total Expenditure
265.44
273.32
308.28
278.97
257.24
225.88
166.07
207.33
191.95
214.10
183.46
Power & Fuel Cost
-
8.29
8.73
7.73
5.89
4.98
4.76
6.38
6.07
6.17
4.66
% Of Sales
-
2.74%
2.57%
2.54%
2.09%
1.99%
2.78%
2.84%
2.90%
2.70%
2.35%
Employee Cost
-
62.40
60.48
55.30
47.25
41.88
50.44
50.28
52.16
45.37
37.30
% Of Sales
-
20.59%
17.83%
18.18%
16.80%
16.72%
29.48%
22.35%
24.92%
19.82%
18.81%
Manufacturing Exp.
-
25.69
29.09
27.76
21.92
18.62
15.80
20.28
18.03
21.44
19.80
% Of Sales
-
8.48%
8.58%
9.12%
7.79%
7.43%
9.23%
9.01%
8.61%
9.37%
9.98%
General & Admin Exp.
-
12.95
13.09
10.16
8.07
5.47
7.48
9.27
11.21
16.82
13.98
% Of Sales
-
4.27%
3.86%
3.34%
2.87%
2.18%
4.37%
4.12%
5.36%
7.35%
7.05%
Selling & Distn. Exp.
-
20.17
18.54
16.36
14.86
10.28
10.61
15.74
15.63
19.50
13.18
% Of Sales
-
6.66%
5.47%
5.38%
5.28%
4.10%
6.20%
7.00%
7.47%
8.52%
6.65%
Miscellaneous Exp.
-
0.71
2.57
2.72
3.51
3.79
1.23
1.33
0.27
0.86
13.18
% Of Sales
-
0.23%
0.76%
0.89%
1.25%
1.51%
0.72%
0.59%
0.13%
0.38%
0.24%
EBITDA
29.16
29.76
30.94
25.25
23.97
24.65
5.02
17.68
17.34
14.81
14.86
EBITDA Margin
9.90%
9.82%
9.12%
8.30%
8.52%
9.84%
2.93%
7.86%
8.29%
6.47%
7.49%
Other Income
2.10
2.20
2.85
0.94
5.15
1.14
1.85
1.01
1.73
3.04
1.28
Interest
16.66
17.05
14.67
12.31
10.91
12.16
12.73
12.74
9.41
8.49
6.48
Depreciation
9.87
9.77
10.07
9.13
9.04
9.52
7.68
6.16
6.77
6.49
7.01
PBT
4.73
5.14
9.05
4.75
9.18
4.10
-13.53
-0.20
2.88
2.87
2.65
Tax
-2.46
-2.10
1.60
2.13
3.48
-0.61
-0.64
-2.36
2.51
3.27
2.39
Tax Rate
-52.01%
-40.86%
17.68%
44.84%
37.91%
-14.88%
4.73%
1180.00%
87.15%
113.94%
90.19%
PAT
7.19
7.22
7.40
2.57
5.61
4.74
-12.22
3.79
2.79
1.75
1.41
PAT before Minority Interest
7.16
7.24
7.45
2.62
5.70
4.71
-12.89
2.15
0.38
-0.40
0.26
Minority Interest
-0.03
-0.02
-0.05
-0.05
-0.09
0.03
0.67
1.64
2.41
2.15
1.15
PAT Margin
2.44%
2.38%
2.18%
0.84%
1.99%
1.89%
-7.14%
1.68%
1.33%
0.76%
0.71%
PAT Growth
-5.52%
-2.43%
187.94%
-54.19%
18.35%
-
-
35.84%
59.43%
24.11%
 
EPS
4.52
4.54
4.65
1.62
3.53
2.98
-7.69
2.38
1.75
1.10
0.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
77.42
72.00
63.79
58.63
53.58
52.43
66.64
64.99
62.45
54.90
Share Capital
15.92
15.80
15.69
14.82
14.82
14.17
14.17
14.17
14.17
12.87
Total Reserves
61.49
56.20
48.10
42.87
37.82
38.25
52.47
50.82
48.27
40.01
Non-Current Liabilities
38.38
44.81
37.97
36.40
34.19
33.56
37.85
45.57
30.02
45.12
Secured Loans
24.70
23.21
14.11
27.01
23.93
22.93
28.76
33.25
12.76
15.24
Unsecured Loans
6.70
13.14
16.42
0.00
0.00
0.22
0.00
1.43
5.04
19.71
Long Term Provisions
5.64
5.09
5.07
4.69
4.07
3.62
2.71
2.05
3.42
2.28
Current Liabilities
219.50
203.06
209.33
165.65
152.53
159.49
163.24
154.40
143.24
111.19
Trade Payables
81.69
77.46
78.92
65.56
47.17
38.67
47.34
49.96
54.43
46.85
Other Current Liabilities
29.34
26.67
31.05
24.21
23.57
30.69
27.86
33.77
16.45
12.01
Short Term Borrowings
107.31
95.76
92.72
70.75
80.82
89.63
87.08
68.31
71.07
50.09
Short Term Provisions
1.17
3.17
6.64
5.12
0.98
0.50
0.96
2.37
1.29
2.24
Total Liabilities
335.29
319.84
311.00
260.55
240.07
238.38
261.31
260.17
233.33
211.03
Net Block
86.81
79.53
76.46
67.39
68.59
70.71
70.39
71.48
59.98
56.23
Gross Block
157.26
140.21
127.10
111.45
105.10
97.70
89.76
84.71
66.44
106.10
Accumulated Depreciation
70.45
60.69
50.64
44.06
36.52
27.00
19.37
13.23
6.46
49.87
Non Current Assets
100.41
85.68
82.85
75.96
75.93
81.02
78.26
75.41
68.78
68.03
Capital Work in Progress
2.79
0.47
0.00
1.61
0.00
3.32
3.63
0.21
1.70
3.93
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.02
0.02
0.02
Long Term Loans & Adv.
6.40
5.23
4.61
5.01
4.86
5.43
1.69
3.15
6.61
7.54
Other Non Current Assets
4.41
0.45
1.78
1.95
2.49
1.56
2.54
0.55
0.46
0.32
Current Assets
234.87
234.16
228.16
184.57
164.15
157.37
183.05
184.77
164.55
143.00
Current Investments
2.47
6.76
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
103.02
87.81
98.00
74.40
60.39
67.71
69.75
66.49
54.73
41.75
Sundry Debtors
92.44
99.62
93.98
75.31
67.20
49.60
64.70
64.05
61.80
56.94
Cash & Bank
8.05
13.29
7.61
5.39
3.85
3.13
4.32
4.15
4.71
4.63
Other Current Assets
28.88
4.58
3.73
12.49
32.71
36.92
44.28
50.07
43.31
39.66
Short Term Loans & Adv.
22.88
22.10
24.83
16.98
28.02
32.85
43.58
49.83
42.45
38.45
Net Current Assets
15.37
31.10
18.82
18.93
11.61
-2.12
19.81
30.36
21.31
31.81
Total Assets
335.28
319.84
311.01
260.53
240.08
238.39
261.31
260.18
233.33
211.03

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
20.32
22.81
-1.54
26.80
22.34
23.24
7.76
0.58
6.31
-19.35
PBT
5.14
9.05
4.75
9.18
4.10
-13.53
-0.20
2.88
2.87
2.65
Adjustment
24.74
22.34
21.74
17.15
21.14
19.01
17.41
15.14
14.79
11.46
Changes in Working Capital
-7.49
-4.04
-27.52
1.66
-2.80
17.94
-7.07
-16.18
-9.95
-32.66
Cash after chg. in Working capital
22.39
27.35
-1.03
28.00
22.45
23.42
10.13
1.84
7.72
-18.55
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.08
-4.54
-0.50
-1.20
-0.11
-0.17
-2.38
-1.27
-1.40
-0.80
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-14.92
-18.89
-22.18
-9.48
-5.53
-4.71
-8.04
-3.56
-7.96
-13.88
Net Fixed Assets
-19.36
-33.15
-13.94
-7.15
-3.66
-6.22
-4.61
-3.80
41.86
-12.93
Net Investments
4.29
-0.52
0.00
0.00
-0.98
0.02
0.00
-7.42
1.16
-0.09
Others
0.15
14.78
-8.24
-2.33
-0.89
1.49
-3.43
7.66
-50.98
-0.86
Cash from Financing Activity
-7.84
-1.21
24.09
-17.22
-16.63
-19.97
0.01
3.53
-5.94
32.37
Net Cash Inflow / Outflow
-2.44
2.71
0.37
0.09
0.17
-1.44
-0.27
0.55
-7.58
-0.86
Opening Cash & Equivalents
4.20
1.49
1.11
1.02
0.86
2.44
2.71
2.16
-17.72
5.49
Closing Cash & Equivalent
1.75
4.20
1.49
1.11
1.02
0.86
2.44
2.71
-25.30
4.63

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
48.63
45.56
40.66
38.92
35.52
36.99
47.02
45.86
44.06
41.09
ROA
2.21%
2.36%
0.92%
2.28%
1.97%
-5.16%
0.83%
0.15%
-0.18%
0.14%
ROE
9.69%
10.97%
4.31%
10.34%
8.97%
-21.65%
3.27%
0.59%
-0.69%
0.49%
ROCE
10.10%
11.67%
9.56%
12.33%
9.72%
-0.44%
6.88%
7.45%
7.59%
7.35%
Fixed Asset Turnover
2.04
2.54
2.55
2.60
2.47
1.83
2.58
2.80
2.72
2.01
Receivable days
115.65
104.16
101.56
92.48
85.08
121.92
104.42
108.60
92.23
91.87
Inventory Days
114.91
99.97
103.42
87.47
93.31
146.63
110.50
104.61
74.94
69.91
Payable days
202.96
162.36
165.90
132.11
111.21
90.28
86.70
99.47
88.16
89.31
Cash Conversion Cycle
27.60
41.77
39.08
47.85
67.18
178.27
128.22
113.74
79.02
72.47
Total Debt/Equity
1.94
1.94
2.05
1.80
2.09
2.26
1.85
1.69
1.49
1.68
Interest Cover
1.30
1.62
1.39
1.84
1.34
-0.06
0.98
1.31
1.34
1.41

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Bal Pharma - Quarterly Results
    11th Aug 2025, 18:09 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.